Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Change in Account Payables (2020 - 2025)

Pulse Biosciences has reported Change in Account Payables over the past 6 years, most recently at -$186000.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at -$186000.0 for Q4 2025, down 2557.14% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 663.18% YoY), and the annual figure for FY2025 was $1.1 million, up 663.18%.
  • Change in Account Payables for Q4 2025 was -$186000.0 at Pulse Biosciences, down from $274000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for PLSE hit a ceiling of $712000.0 in Q1 2025 and a floor of -$1.5 million in Q2 2022.
  • Median Change in Account Payables over the past 5 years was $64000.0 (2022), compared with a mean of $52500.0.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 6855.56% in 2021 and later tumbled 2557.14% in 2025.
  • Pulse Biosciences' Change in Account Payables stood at $185000.0 in 2021, then plummeted by 321.08% to -$409000.0 in 2022, then surged by 206.85% to $437000.0 in 2023, then tumbled by 101.6% to -$7000.0 in 2024, then tumbled by 2557.14% to -$186000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$186000.0 (Q4 2025), $274000.0 (Q3 2025), and $332000.0 (Q2 2025) per Business Quant data.